Drugs / NTHi-10-AS01E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02075541 | Jul 2014 → Apr 2017 | respiratory system disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NTHi-10-AS01E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02075541 ↗ |
| Modality | Vaccine | “an investigational vaccine containing NTHi antigens, recombinant protein D (PD) and combined protein E and Pilin A (PE-PilA), and AS01 adjuvant” PMID 31447126 ↗ Aug 2019 |
| Route | Intramuscular | “Intramuscular vaccination in the deltoid region of the non-dominant arm according to protocol schedule.” NCT02075541 ↗ |